SlideShare ist ein Scribd-Unternehmen logo
1 von 49
Downloaden Sie, um offline zu lesen
Revealing Human Embryos:
Morphology And Contents
April 21, 2017
Ragaa Mansour, M.D., Ph.D.
Director, The Egyptian IVF-ET Center
Successful reproduction has always been
considered as a ̋ Miracle ̏
Cow uterus
The ancient Egyptians
had a ̋ Neteru ̏ of
childbirth and creator
of the ̋ Ka.̏
(Meskhenet)
with a symble of cow
uterus
Westcard Papyrus
Fifth Dynasty (2494 BC)
de Graaf described a bisected ovary, with the follicles
thought to be the actual ova.
In recent times:
1675
In 1827 von Baer in St. Petersburg discovered the true ovule
within the Grafian follicle.
150 years later
In 1939, Gregory Pincus was the first to show how rabbit
oocytes aspirated from their follicles would begin their
maturation in- vitro.
He also was the first to extract oocytes from excised human
ovaries and mature them in-vitro.
100 years later
1952 – 1957
In Edinburgh
1957 - 1960
In California
- PMS and hCG
- Endocrine control of
ovulation, and artificial
insemination
15 years later
Robert Edwards
Repeated pincus work but on mouse oocytes
̋ Nature 1962 ̏
̋ Lancet 1965̏
Bob Edwards was confident enough to work with
Human Oocytes
Molly Rose
(UK)
Howard &
Georgina Johns
(USA)
Dr. Victor Lewis
(UK)
He asked clinical doctors for slithers or wedges of ovaries from
patients with PCO, or excised ovaries for other conditions.
̋ That evening in 1969 we watched in delight virtually all stages
of human fertilization in vitro ̏ .
Bob Edwards surprised the world unaccustomed to the
idea of human fertilization in-vitro
Robert Edwards
Nature,1969
Edwards telephoned steptoe, and ever since their long and
revolutionary collaboration started.
Steptoe PC, Laparoscopy and ovulation. The Lancet 1968
Oocytes came in a steady stream and were successfully
fertilized and grown beautifully to the stage of blastocyst.
̋ Naturȅ 1971- Human blastocysts grown in culture
Steptoe PC, Edwards RG, Purdy JM
̋ The first clinical pregnancy arose after the transfer of a single blastocyst ̏
Two years later the first IVF baby was born
Lancet 1976, Steptoe PC, Edwards RG. Reimplantation
of a human embryo with subsequent tubal pregnancy
̋ We are indeed enmeshed in some of the most fundamental
evolutionary stages of our existence as we pass from oocyte to
blastocyst and to implantation ̏.
And gradually IVF Labs worldwide increased steadily
̋ Robert Edwards
̏
2 PN
blastocyst
morula
How to select the best? I- Morphology
- Good quality MII oocyte has
regular size, clear moderately
granulate cytoplasm, a small
perivitelline space, colorless
zona, and intact PB (1)
- Heavily fragmented PB, dense
central granulation, and vacuoles
> 14µm are negative predictors of
embryo quality, IR, and PR (2)
- 6.6% of 1000 ICSI cycles had
abnormal oocyte morphology (3)
(1) Ebner et al., 2003 (2) Ebner et al., 2005 (3) Mansour et al.,1998
Scoring for fertilization
• At 16-20 hours post insemination two centrally aligned PN, with 2
PB located near the PN axis is a good sign. Any deviation could lead
to reduced morphology. (1,2)
• However, PN morphology is an unstable factor within the
dynamic process of fertilization. And recently it was suggested
to stop scoring PN all together. (3)
(1) Edwards and Beard , 1997 (2) Gianaroli et al., 2003 (3) Allan Handyside, 2016
3 PN zygots should be spotted and cultured separately
● Human triploids originate mostly from dispermic fertilization and
less frequently from digynic oocytes.
● It often develops to partial hydatiform mole. Occasionally they can
develop and reach term with early neonatal death.
Evaluation of the cleaving embryos
- number of balstomeres, equal
in size and symmetrical with a
visible nucleus and no
fragmentation.
- Multinucleation, unequal
blastomeres, as well as large
amount of fragmentation are
potential source of aneuploidy.
(Johanson et al., 2003, Ziebe et al., 1997, van Royen et al., 1999, Hardarson et al., 2001
Embryos should follow a specific time line for development
Thomas Ebner
D5
D4
D3
D2
D1
D0
0 h
23-29 h
66-70 h
114-120 h
18-24 h
42-44 h
90-100 h
Extended culture
Advances in our knowledge of in-vitro culture conditions
and the development of better culture media facilitated
extended culture.
(Gardner et al., 1998)
Cohesive trophectoderm
with numerous sickle-
shaped cells
Extended culture facilitated Embryo Selection
Tightly packed slightly
oval inner cell mass >
4500 µm.
(Richter et al., 2001, Kovacic et al., 2004, Gardner et al., 2000
Viable Blastocyst
Cochrane database, March 2016 (27 RCT)
Clinical pregnancy rate
39-46%
OR 1.3
Moderate quality evidence
36%
Live birth rate
32 – 42%
OR 1.48
Low quality evidence
29%
Cumulative pregnancy rate
NO Difference
OR 0.89
Very low quality evidence
Multiple pregnancy rate
Miscarriage rate
NO Difference
OR 1.05, 1.15
low quality evidence
Freezing rate
37 -46% 60%
OR 0.48
Low quality evidence
Cancelled ET
2 -4%
OR 2.5
Moderate quality evidence
1%
Time lapse imaging
Multicenter study on > 1500 embryos of known outcome: →
50.6% of embryos that resulted in pregnancy were
categorized as non suitable, using the time laps.
(kirkegaard et al 2014)
Precise evaluation of morphology and finding a
dynamic marker of embryo quality
Time lapse imaging
Cochrane database, 2015
There is no evidence of a difference in the live
birth, miscarriage, still birth, or clinical pregnancy
rate per couple randomly assigned to either time
lapse system or conventional incubator.
We need an intelligent computer software to analyze precise
pattern and timing of embryo division and solve the algorithm
of embryo selection.
The algorithm of embryo selection
EEVA
II. Contents
are these beautiful embryos euploid?
Rabinowitz et al., 2012
More than half of human embryos generated during IVF
contain aneuploid cells.
274 embryos, only 27.7% were euploid.
We do not know
Yes !
(Hasold et al 1996, Vialard et al, 2001) Rabinowitz et al., 2012
(Gabriel et al 2011) Santiago Monne 2016
PGDIS, Bolognia
Are we actually causing aneuploidy as we do IVF/ICSI?
Allan Handyside 2016
- Analysis of large data from oocyte donor cycles that underwent PGS
in different centers showed different aneuploidy rates and even
between doctors from the same center.
- Aneuploidy is the most common type of chromosome abnormality,
and it is the leading cause of implantation failure, miscarriage, and
congenital anomalies in humans.
segregation of a whole chromosome to the same pole as its homologue
(non-disjunction), or chromatid precocious separation errors.
Aneuploidy
The presence of extra or missing chromosomes
Preimplantation Genetic Testing (PGT)
Obtaining a biopsy from the embryo for genetic testing before its
transfer into the uterus. It is indicated for :
1- patients at high risk of transmitting a genetic abnormality to
their children:
a) all monogenic defects.
b) carriers of balanced translocations, or
numerical chromosomal anomalies.
2- aneuploidy screening
Clinical
PR/per ET
# ET procedures
Cycles
(OR)
Procedures
27%
14,482 (72%)
20,207
Aneuploidy Screening
29%
4,758 (78%)
6,096
Single gene defects
27%
3,219 (64%)
5,027
Chromosomal anomalies
25%
955 (76%)
1,263
Sexing for X linked diseases
29%
494 (73%)
676
Social sexing
Indications of genetic testing
(ESHRE PGD Consortium) Moultou et al 2014
Meta analysis of aneuploidy screening
Lee et al., 2015 (Hum Reprod)
 19 articles: 3 RCTs, and 16 observational.
 Overall, there are potential benefits of aneuploidy screening
resulting in a higher IR.
 The three RCTs done for good prognosis patients
demonstrated clinical benefit in terms of improved clinical
PR and the use of single ET.
 A new and powerful technique to help us select the best
embryos is karyomapping.
 It works well for translocation diagnosis in addition to
aneuploidy screening.
Karyomapping
Allan Handyside, 2016
(PGDIS meeting)
Karyomapping is like a finger print.
It detects single
gene defect, and
chromosomal
aneuploidy
Rechitsky & Kuliev, 2015
Mitochondrial Content
Another important indicator for implantation potential of an
embryo is the mitochondrial content.
In 2014 a microarray platform was developed to allow
simultaneous assessment of aneuploidy and quantification of
mitochondrial DNA content in human embryos.
Konstantinidis et al., 2014
Diez-Juan et al., 2015
E Fragouli et al., 2015
High mt DNA copy number in embryos is indicative of a lower
embryo quality and is associated with lower implantation rates.
Less is Better
The Future: ̋ Single Euploid Embryo Transfer ̏
̋ Holy Grail in IVF ̏
The technology is going there →
PGD and PGS plus mitochondrial DNA at the same time →
69-72% implantation rates
Allan Trounson 2016
Allan Handyside, 2016
Rechitsky & Kulieve, 2015
What about ?
- If a patient has no blastocyst (2-4%)
or
- If a patient has no euploid embryos (10%)
Chchrane data base, 2016
Dagan Wells, 2016
Santiago Mumme,2016
PGDIS meeting
 Give all the embryos a chance.
 Transfer every single embryo.
Allan Handyside, 2016
(PGDIS meeting)
Wise Advice
Give every single embryo a chance
 A mosaic embryo has a potential of making a
healthy baby (about 50% of the potential of a
normal embryo). It resulted in a 16% live birth rate.
Dagan Wells, 2016
Santiago Munne,2016
PGDIS meeting
Analysis of the embryo surroundings
I- spent embryo culture medium
1- The protein translated from specific gene expression
products (proteomics)
2- Metabolic biomarkers
3- RNA-based negative regulators of gene expression
(micro RNA).
II- Cumulus cells.
Micro RNA
Three micro RNA (mi R-3729, mi R-191, mi R-645) were
differentially expressed on day 5 of embryos that had successful
pregnancy.
However the analysis is challenging and more research is ongoing .
-Bagga et al., 2005
-Rodgaard et al, 2015
-Calliano et al, 2015
Biochemical Markers for embryo viability
I- Glycolytic activity
- Both pyruvate and glucose uptake
significantly increase in cleaving embryos
that developed to blastocyst stage.
- Glucose (but not pyruvate) uptake
significantly increase in blastocysts
of highest grade.
- Gardner et al., 2001
Biochemical Markers for embryo viability
II- Amino acid turnover
- Leucin
The only amino acid depleted in the cleaving embryos
that progressed to blastocyst.
- Alanine
Has a striking net appearance due to involvement in
disposal of embryo toxic ammonium ions.
-Houghton et al., 2002
Biochemical criteria of metabolic activity
Unfortunately the required techniques for detection of
biochemical markers such as ultramicroflurescence, and high-
performance liquid chromatography are not usually available in
standard IVF labs, thus limiting their application in routine work.
Thomas Ebner, 2010
Conclusions
1- Morphology and rate of cleavage are still the foremost
methods of embryo selection.
2- The developmental fate of an embryo is largely dictated by
the quality of the oocyte.
3- PN morphology is an unstable factor within the dynamic
process of fertilization.
Conclusions
4- The time of the first mitotic cleavage is a reliable indicator of
embryo viability.
5- Multinucleation and asymmetrical cleavage are documented
to reduce viability.
6- Extended culture facilitated selection from embryos that
reached blastocyst stage.
Conclusions
7- The implantation and pregnancy rates with blastocyst transfer
are significantly higher than cleavage stage transfer.
8- An intelligent software algorithm to analyze images from time
laps systems is needed.
9- Detection of biochemical markers, proteomics, and micro
RNA are not currently applicable for routine work in IVF
Labs.
Conclusions
10 - The future is for genetic testing.
aneuploidy screening + single gene defect
+ mt DNA content at the same time.
(69-72% implantation rates)
Conclusions
11 -1n poor prognosis patients we have to give every single
embryo a chance.
12- Combining morphological evaluation, cytogenetical
analysis, and embryo metabolism will increase the ability
to select the most viable embryo out of a pool.
Everyone is a miracle in miniature with a personal
history of men and women who lived, loved, and gave
birth to others ever since the creation of mankind.
Harvey Graham 1950
No body is genetically perfect

Weitere ähnliche Inhalte

Was ist angesagt?

Pitfalls in management of infertility
Pitfalls in management of infertilityPitfalls in management of infertility
Pitfalls in management of infertilityHesham Al-Inany
 
Adjuvant procedures in IVF
Adjuvant procedures in IVFAdjuvant procedures in IVF
Adjuvant procedures in IVFWalid Ahmed
 
Reproductive Immunology
Reproductive ImmunologyReproductive Immunology
Reproductive ImmunologySujoy Dasgupta
 
Recurrant Implantation Failure in IVF
Recurrant Implantation Failure in IVFRecurrant Implantation Failure in IVF
Recurrant Implantation Failure in IVFKaberi Banerjee
 
Immunological issues in recurrent implant failure
Immunological issues in recurrent implant failureImmunological issues in recurrent implant failure
Immunological issues in recurrent implant failureArunSharma10
 
2021 Gonadotropins for controlled ovarian hyperstimulation
2021 Gonadotropins for controlled ovarian hyperstimulation2021 Gonadotropins for controlled ovarian hyperstimulation
2021 Gonadotropins for controlled ovarian hyperstimulationHesham Al-Inany
 
Free Information Session 5th September 2012: Recent Breakthroughs in IVF
Free Information Session 5th September 2012:  Recent Breakthroughs in IVFFree Information Session 5th September 2012:  Recent Breakthroughs in IVF
Free Information Session 5th September 2012: Recent Breakthroughs in IVFFertility SA
 
Future of IVF : scoping view
Future of IVF : scoping viewFuture of IVF : scoping view
Future of IVF : scoping viewHesham Al-Inany
 
Ovarian Hyperstimulation in Intrauterine Insemination
Ovarian Hyperstimulation in Intrauterine InseminationOvarian Hyperstimulation in Intrauterine Insemination
Ovarian Hyperstimulation in Intrauterine InseminationElmar Breitbach
 
Management of IVF Pregnancy
Management of IVF PregnancyManagement of IVF Pregnancy
Management of IVF PregnancyKaberi Banerjee
 
Fertility preservation Egg freezing
Fertility preservation  Egg freezing   Fertility preservation  Egg freezing
Fertility preservation Egg freezing NikosFVlahosMDPhD
 
Blastocyst Culture Benefit and Harms
Blastocyst Culture  Benefit and HarmsBlastocyst Culture  Benefit and Harms
Blastocyst Culture Benefit and HarmsDr. Jyoti Malik
 
Estradiol Valerate in Fertility Care: New Vistas
Estradiol Valerate in Fertility Care: New VistasEstradiol Valerate in Fertility Care: New Vistas
Estradiol Valerate in Fertility Care: New VistasSujoy Dasgupta
 
Antagonist - Tips and tricks to optimize use in Intra Uterine Insemination (I...
Antagonist - Tips and tricks to optimize use in Intra Uterine Insemination (I...Antagonist - Tips and tricks to optimize use in Intra Uterine Insemination (I...
Antagonist - Tips and tricks to optimize use in Intra Uterine Insemination (I...Anu Test Tube Baby Centre
 

Was ist angesagt? (20)

Pitfalls in management of infertility
Pitfalls in management of infertilityPitfalls in management of infertility
Pitfalls in management of infertility
 
Letrozol & reproduction
Letrozol & reproductionLetrozol & reproduction
Letrozol & reproduction
 
Adjuvant procedures in IVF
Adjuvant procedures in IVFAdjuvant procedures in IVF
Adjuvant procedures in IVF
 
Reproductive Immunology
Reproductive ImmunologyReproductive Immunology
Reproductive Immunology
 
Adjuvant therapy
Adjuvant therapyAdjuvant therapy
Adjuvant therapy
 
GnRH costeffectiveness
GnRH costeffectivenessGnRH costeffectiveness
GnRH costeffectiveness
 
Recurrant Implantation Failure in IVF
Recurrant Implantation Failure in IVFRecurrant Implantation Failure in IVF
Recurrant Implantation Failure in IVF
 
Covid & reproduction
Covid & reproductionCovid & reproduction
Covid & reproduction
 
Immunological issues in recurrent implant failure
Immunological issues in recurrent implant failureImmunological issues in recurrent implant failure
Immunological issues in recurrent implant failure
 
2021 Gonadotropins for controlled ovarian hyperstimulation
2021 Gonadotropins for controlled ovarian hyperstimulation2021 Gonadotropins for controlled ovarian hyperstimulation
2021 Gonadotropins for controlled ovarian hyperstimulation
 
Free Information Session 5th September 2012: Recent Breakthroughs in IVF
Free Information Session 5th September 2012:  Recent Breakthroughs in IVFFree Information Session 5th September 2012:  Recent Breakthroughs in IVF
Free Information Session 5th September 2012: Recent Breakthroughs in IVF
 
Future of IVF : scoping view
Future of IVF : scoping viewFuture of IVF : scoping view
Future of IVF : scoping view
 
Ovarian Hyperstimulation in Intrauterine Insemination
Ovarian Hyperstimulation in Intrauterine InseminationOvarian Hyperstimulation in Intrauterine Insemination
Ovarian Hyperstimulation in Intrauterine Insemination
 
Management of IVF Pregnancy
Management of IVF PregnancyManagement of IVF Pregnancy
Management of IVF Pregnancy
 
Fertility preservation Egg freezing
Fertility preservation  Egg freezing   Fertility preservation  Egg freezing
Fertility preservation Egg freezing
 
Implantation Failure in IVF
Implantation Failure in IVFImplantation Failure in IVF
Implantation Failure in IVF
 
Blastocyst Culture Benefit and Harms
Blastocyst Culture  Benefit and HarmsBlastocyst Culture  Benefit and Harms
Blastocyst Culture Benefit and Harms
 
AMH & its Clinical Implications.pptx
AMH & its Clinical Implications.pptxAMH & its Clinical Implications.pptx
AMH & its Clinical Implications.pptx
 
Estradiol Valerate in Fertility Care: New Vistas
Estradiol Valerate in Fertility Care: New VistasEstradiol Valerate in Fertility Care: New Vistas
Estradiol Valerate in Fertility Care: New Vistas
 
Antagonist - Tips and tricks to optimize use in Intra Uterine Insemination (I...
Antagonist - Tips and tricks to optimize use in Intra Uterine Insemination (I...Antagonist - Tips and tricks to optimize use in Intra Uterine Insemination (I...
Antagonist - Tips and tricks to optimize use in Intra Uterine Insemination (I...
 

Ähnlich wie Revealing human embryos,ragaa mansour

Recent Trends In Art
Recent Trends In ArtRecent Trends In Art
Recent Trends In Artguest7f0a3a
 
Recent Trends In Art (2)
Recent Trends In Art (2)Recent Trends In Art (2)
Recent Trends In Art (2)guest7f0a3a
 
Recent Trends In Art (1)
Recent Trends In Art (1)Recent Trends In Art (1)
Recent Trends In Art (1)guest7f0a3a
 
Day3 versus Day5 Embryo Transfer
Day3 versus Day5 Embryo TransferDay3 versus Day5 Embryo Transfer
Day3 versus Day5 Embryo TransferSujoy Dasgupta
 
1 s2.0-s1472648313006366-main
1 s2.0-s1472648313006366-main1 s2.0-s1472648313006366-main
1 s2.0-s1472648313006366-main鋒博 蔡
 
1 s2.0-s1472648313005798-main
1 s2.0-s1472648313005798-main1 s2.0-s1472648313005798-main
1 s2.0-s1472648313005798-main鋒博 蔡
 
Preimplantation genetic screening (pgs) current ppt
Preimplantation genetic screening (pgs)  current     pptPreimplantation genetic screening (pgs)  current     ppt
Preimplantation genetic screening (pgs) current ppt鋒博 蔡
 
Preimplantation genetic screening (pgs) current ppt
Preimplantation genetic screening (pgs)  current     pptPreimplantation genetic screening (pgs)  current     ppt
Preimplantation genetic screening (pgs) current ppt鋒博 蔡
 
Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3Lifecare Centre
 
Scoring of embryos by Dr.Renukadevi
Scoring of embryos by Dr.RenukadeviScoring of embryos by Dr.Renukadevi
Scoring of embryos by Dr.RenukadeviMorris Jawahar
 
Mjd presentation1
Mjd presentation1Mjd presentation1
Mjd presentation1鋒博 蔡
 
Mjd presentation1
Mjd presentation1Mjd presentation1
Mjd presentation1鋒博 蔡
 
Mjd presentation1 (4)
Mjd presentation1 (4)Mjd presentation1 (4)
Mjd presentation1 (4)t7260678
 

Ähnlich wie Revealing human embryos,ragaa mansour (20)

Recent Trends In Art
Recent Trends In ArtRecent Trends In Art
Recent Trends In Art
 
Recent Trends In Art (2)
Recent Trends In Art (2)Recent Trends In Art (2)
Recent Trends In Art (2)
 
Recent Trends In Art (1)
Recent Trends In Art (1)Recent Trends In Art (1)
Recent Trends In Art (1)
 
Day3 versus Day5 Embryo Transfer
Day3 versus Day5 Embryo TransferDay3 versus Day5 Embryo Transfer
Day3 versus Day5 Embryo Transfer
 
1 s2.0-s1472648313006366-main
1 s2.0-s1472648313006366-main1 s2.0-s1472648313006366-main
1 s2.0-s1472648313006366-main
 
1 s2.0-s1472648313005798-main
1 s2.0-s1472648313005798-main1 s2.0-s1472648313005798-main
1 s2.0-s1472648313005798-main
 
Preimplantation genetic screening (pgs) current ppt
Preimplantation genetic screening (pgs)  current     pptPreimplantation genetic screening (pgs)  current     ppt
Preimplantation genetic screening (pgs) current ppt
 
Preimplantation genetic screening (pgs) current ppt
Preimplantation genetic screening (pgs)  current     pptPreimplantation genetic screening (pgs)  current     ppt
Preimplantation genetic screening (pgs) current ppt
 
35170
3517035170
35170
 
35170
3517035170
35170
 
35170
3517035170
35170
 
Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3
 
History of embryology
History of embryologyHistory of embryology
History of embryology
 
In Vitro Fertilizatin
In Vitro FertilizatinIn Vitro Fertilizatin
In Vitro Fertilizatin
 
P lo s on
P lo s onP lo s on
P lo s on
 
Twin pregnancy
Twin pregnancyTwin pregnancy
Twin pregnancy
 
Scoring of embryos by Dr.Renukadevi
Scoring of embryos by Dr.RenukadeviScoring of embryos by Dr.Renukadevi
Scoring of embryos by Dr.Renukadevi
 
Mjd presentation1
Mjd presentation1Mjd presentation1
Mjd presentation1
 
Mjd presentation1
Mjd presentation1Mjd presentation1
Mjd presentation1
 
Mjd presentation1 (4)
Mjd presentation1 (4)Mjd presentation1 (4)
Mjd presentation1 (4)
 

Mehr von Hesham Al-Inany (17)

Updated HRT.pptx
Updated HRT.pptxUpdated HRT.pptx
Updated HRT.pptx
 
errors.pptx
errors.pptxerrors.pptx
errors.pptx
 
EndometriosisUpdate.pptx
EndometriosisUpdate.pptxEndometriosisUpdate.pptx
EndometriosisUpdate.pptx
 
DienogestMEFS.pptx
DienogestMEFS.pptxDienogestMEFS.pptx
DienogestMEFS.pptx
 
4G O.I.pptx
4G O.I.pptx4G O.I.pptx
4G O.I.pptx
 
miscarriage.pptx
miscarriage.pptxmiscarriage.pptx
miscarriage.pptx
 
OBGYNTech.pptx
OBGYNTech.pptxOBGYNTech.pptx
OBGYNTech.pptx
 
progesterone & Miscarriage.pptx
progesterone & Miscarriage.pptxprogesterone & Miscarriage.pptx
progesterone & Miscarriage.pptx
 
How to use technology to improve data integrity.pptx
How to use technology to improve data integrity.pptxHow to use technology to improve data integrity.pptx
How to use technology to improve data integrity.pptx
 
Updated hormone replacement therapy
Updated hormone replacement therapyUpdated hormone replacement therapy
Updated hormone replacement therapy
 
Fibroid & infertility
Fibroid & infertilityFibroid & infertility
Fibroid & infertility
 
Prima IVF poor responders
Prima IVF  poor respondersPrima IVF  poor responders
Prima IVF poor responders
 
Adenomyosis
AdenomyosisAdenomyosis
Adenomyosis
 
Ocp 24
Ocp 24Ocp 24
Ocp 24
 
Errors in IVF
Errors in IVFErrors in IVF
Errors in IVF
 
Rpl vascuar
Rpl vascuarRpl vascuar
Rpl vascuar
 
Abuse
AbuseAbuse
Abuse
 

Kürzlich hochgeladen

Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 

Kürzlich hochgeladen (20)

Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 

Revealing human embryos,ragaa mansour

  • 1. Revealing Human Embryos: Morphology And Contents April 21, 2017 Ragaa Mansour, M.D., Ph.D. Director, The Egyptian IVF-ET Center
  • 2. Successful reproduction has always been considered as a ̋ Miracle ̏ Cow uterus The ancient Egyptians had a ̋ Neteru ̏ of childbirth and creator of the ̋ Ka.̏ (Meskhenet) with a symble of cow uterus Westcard Papyrus Fifth Dynasty (2494 BC)
  • 3. de Graaf described a bisected ovary, with the follicles thought to be the actual ova. In recent times: 1675
  • 4. In 1827 von Baer in St. Petersburg discovered the true ovule within the Grafian follicle. 150 years later
  • 5. In 1939, Gregory Pincus was the first to show how rabbit oocytes aspirated from their follicles would begin their maturation in- vitro. He also was the first to extract oocytes from excised human ovaries and mature them in-vitro. 100 years later
  • 6. 1952 – 1957 In Edinburgh 1957 - 1960 In California - PMS and hCG - Endocrine control of ovulation, and artificial insemination 15 years later Robert Edwards Repeated pincus work but on mouse oocytes
  • 7. ̋ Nature 1962 ̏ ̋ Lancet 1965̏ Bob Edwards was confident enough to work with Human Oocytes Molly Rose (UK) Howard & Georgina Johns (USA) Dr. Victor Lewis (UK) He asked clinical doctors for slithers or wedges of ovaries from patients with PCO, or excised ovaries for other conditions.
  • 8. ̋ That evening in 1969 we watched in delight virtually all stages of human fertilization in vitro ̏ . Bob Edwards surprised the world unaccustomed to the idea of human fertilization in-vitro Robert Edwards Nature,1969
  • 9. Edwards telephoned steptoe, and ever since their long and revolutionary collaboration started. Steptoe PC, Laparoscopy and ovulation. The Lancet 1968
  • 10. Oocytes came in a steady stream and were successfully fertilized and grown beautifully to the stage of blastocyst. ̋ Naturȅ 1971- Human blastocysts grown in culture Steptoe PC, Edwards RG, Purdy JM
  • 11. ̋ The first clinical pregnancy arose after the transfer of a single blastocyst ̏ Two years later the first IVF baby was born Lancet 1976, Steptoe PC, Edwards RG. Reimplantation of a human embryo with subsequent tubal pregnancy
  • 12. ̋ We are indeed enmeshed in some of the most fundamental evolutionary stages of our existence as we pass from oocyte to blastocyst and to implantation ̏. And gradually IVF Labs worldwide increased steadily ̋ Robert Edwards ̏ 2 PN blastocyst morula
  • 13. How to select the best? I- Morphology - Good quality MII oocyte has regular size, clear moderately granulate cytoplasm, a small perivitelline space, colorless zona, and intact PB (1) - Heavily fragmented PB, dense central granulation, and vacuoles > 14µm are negative predictors of embryo quality, IR, and PR (2) - 6.6% of 1000 ICSI cycles had abnormal oocyte morphology (3) (1) Ebner et al., 2003 (2) Ebner et al., 2005 (3) Mansour et al.,1998
  • 14. Scoring for fertilization • At 16-20 hours post insemination two centrally aligned PN, with 2 PB located near the PN axis is a good sign. Any deviation could lead to reduced morphology. (1,2) • However, PN morphology is an unstable factor within the dynamic process of fertilization. And recently it was suggested to stop scoring PN all together. (3) (1) Edwards and Beard , 1997 (2) Gianaroli et al., 2003 (3) Allan Handyside, 2016
  • 15. 3 PN zygots should be spotted and cultured separately ● Human triploids originate mostly from dispermic fertilization and less frequently from digynic oocytes. ● It often develops to partial hydatiform mole. Occasionally they can develop and reach term with early neonatal death.
  • 16. Evaluation of the cleaving embryos - number of balstomeres, equal in size and symmetrical with a visible nucleus and no fragmentation. - Multinucleation, unequal blastomeres, as well as large amount of fragmentation are potential source of aneuploidy. (Johanson et al., 2003, Ziebe et al., 1997, van Royen et al., 1999, Hardarson et al., 2001
  • 17. Embryos should follow a specific time line for development Thomas Ebner D5 D4 D3 D2 D1 D0 0 h 23-29 h 66-70 h 114-120 h 18-24 h 42-44 h 90-100 h
  • 18. Extended culture Advances in our knowledge of in-vitro culture conditions and the development of better culture media facilitated extended culture. (Gardner et al., 1998)
  • 19. Cohesive trophectoderm with numerous sickle- shaped cells Extended culture facilitated Embryo Selection Tightly packed slightly oval inner cell mass > 4500 µm. (Richter et al., 2001, Kovacic et al., 2004, Gardner et al., 2000 Viable Blastocyst
  • 20. Cochrane database, March 2016 (27 RCT) Clinical pregnancy rate 39-46% OR 1.3 Moderate quality evidence 36% Live birth rate 32 – 42% OR 1.48 Low quality evidence 29% Cumulative pregnancy rate NO Difference OR 0.89 Very low quality evidence Multiple pregnancy rate Miscarriage rate NO Difference OR 1.05, 1.15 low quality evidence Freezing rate 37 -46% 60% OR 0.48 Low quality evidence Cancelled ET 2 -4% OR 2.5 Moderate quality evidence 1%
  • 21. Time lapse imaging Multicenter study on > 1500 embryos of known outcome: → 50.6% of embryos that resulted in pregnancy were categorized as non suitable, using the time laps. (kirkegaard et al 2014) Precise evaluation of morphology and finding a dynamic marker of embryo quality
  • 22. Time lapse imaging Cochrane database, 2015 There is no evidence of a difference in the live birth, miscarriage, still birth, or clinical pregnancy rate per couple randomly assigned to either time lapse system or conventional incubator.
  • 23. We need an intelligent computer software to analyze precise pattern and timing of embryo division and solve the algorithm of embryo selection. The algorithm of embryo selection EEVA
  • 24. II. Contents are these beautiful embryos euploid? Rabinowitz et al., 2012 More than half of human embryos generated during IVF contain aneuploid cells. 274 embryos, only 27.7% were euploid. We do not know
  • 25. Yes ! (Hasold et al 1996, Vialard et al, 2001) Rabinowitz et al., 2012 (Gabriel et al 2011) Santiago Monne 2016 PGDIS, Bolognia Are we actually causing aneuploidy as we do IVF/ICSI? Allan Handyside 2016 - Analysis of large data from oocyte donor cycles that underwent PGS in different centers showed different aneuploidy rates and even between doctors from the same center. - Aneuploidy is the most common type of chromosome abnormality, and it is the leading cause of implantation failure, miscarriage, and congenital anomalies in humans.
  • 26. segregation of a whole chromosome to the same pole as its homologue (non-disjunction), or chromatid precocious separation errors. Aneuploidy The presence of extra or missing chromosomes
  • 27. Preimplantation Genetic Testing (PGT) Obtaining a biopsy from the embryo for genetic testing before its transfer into the uterus. It is indicated for : 1- patients at high risk of transmitting a genetic abnormality to their children: a) all monogenic defects. b) carriers of balanced translocations, or numerical chromosomal anomalies. 2- aneuploidy screening
  • 28. Clinical PR/per ET # ET procedures Cycles (OR) Procedures 27% 14,482 (72%) 20,207 Aneuploidy Screening 29% 4,758 (78%) 6,096 Single gene defects 27% 3,219 (64%) 5,027 Chromosomal anomalies 25% 955 (76%) 1,263 Sexing for X linked diseases 29% 494 (73%) 676 Social sexing Indications of genetic testing (ESHRE PGD Consortium) Moultou et al 2014
  • 29. Meta analysis of aneuploidy screening Lee et al., 2015 (Hum Reprod)  19 articles: 3 RCTs, and 16 observational.  Overall, there are potential benefits of aneuploidy screening resulting in a higher IR.  The three RCTs done for good prognosis patients demonstrated clinical benefit in terms of improved clinical PR and the use of single ET.
  • 30.  A new and powerful technique to help us select the best embryos is karyomapping.  It works well for translocation diagnosis in addition to aneuploidy screening. Karyomapping Allan Handyside, 2016 (PGDIS meeting)
  • 31. Karyomapping is like a finger print. It detects single gene defect, and chromosomal aneuploidy
  • 33. Mitochondrial Content Another important indicator for implantation potential of an embryo is the mitochondrial content. In 2014 a microarray platform was developed to allow simultaneous assessment of aneuploidy and quantification of mitochondrial DNA content in human embryos. Konstantinidis et al., 2014
  • 34. Diez-Juan et al., 2015 E Fragouli et al., 2015 High mt DNA copy number in embryos is indicative of a lower embryo quality and is associated with lower implantation rates. Less is Better
  • 35. The Future: ̋ Single Euploid Embryo Transfer ̏ ̋ Holy Grail in IVF ̏ The technology is going there → PGD and PGS plus mitochondrial DNA at the same time → 69-72% implantation rates Allan Trounson 2016 Allan Handyside, 2016 Rechitsky & Kulieve, 2015
  • 36. What about ? - If a patient has no blastocyst (2-4%) or - If a patient has no euploid embryos (10%) Chchrane data base, 2016 Dagan Wells, 2016 Santiago Mumme,2016 PGDIS meeting
  • 37.  Give all the embryos a chance.  Transfer every single embryo. Allan Handyside, 2016 (PGDIS meeting) Wise Advice
  • 38. Give every single embryo a chance  A mosaic embryo has a potential of making a healthy baby (about 50% of the potential of a normal embryo). It resulted in a 16% live birth rate. Dagan Wells, 2016 Santiago Munne,2016 PGDIS meeting
  • 39. Analysis of the embryo surroundings I- spent embryo culture medium 1- The protein translated from specific gene expression products (proteomics) 2- Metabolic biomarkers 3- RNA-based negative regulators of gene expression (micro RNA). II- Cumulus cells.
  • 40. Micro RNA Three micro RNA (mi R-3729, mi R-191, mi R-645) were differentially expressed on day 5 of embryos that had successful pregnancy. However the analysis is challenging and more research is ongoing . -Bagga et al., 2005 -Rodgaard et al, 2015 -Calliano et al, 2015
  • 41. Biochemical Markers for embryo viability I- Glycolytic activity - Both pyruvate and glucose uptake significantly increase in cleaving embryos that developed to blastocyst stage. - Glucose (but not pyruvate) uptake significantly increase in blastocysts of highest grade. - Gardner et al., 2001
  • 42. Biochemical Markers for embryo viability II- Amino acid turnover - Leucin The only amino acid depleted in the cleaving embryos that progressed to blastocyst. - Alanine Has a striking net appearance due to involvement in disposal of embryo toxic ammonium ions. -Houghton et al., 2002
  • 43. Biochemical criteria of metabolic activity Unfortunately the required techniques for detection of biochemical markers such as ultramicroflurescence, and high- performance liquid chromatography are not usually available in standard IVF labs, thus limiting their application in routine work. Thomas Ebner, 2010
  • 44. Conclusions 1- Morphology and rate of cleavage are still the foremost methods of embryo selection. 2- The developmental fate of an embryo is largely dictated by the quality of the oocyte. 3- PN morphology is an unstable factor within the dynamic process of fertilization.
  • 45. Conclusions 4- The time of the first mitotic cleavage is a reliable indicator of embryo viability. 5- Multinucleation and asymmetrical cleavage are documented to reduce viability. 6- Extended culture facilitated selection from embryos that reached blastocyst stage.
  • 46. Conclusions 7- The implantation and pregnancy rates with blastocyst transfer are significantly higher than cleavage stage transfer. 8- An intelligent software algorithm to analyze images from time laps systems is needed. 9- Detection of biochemical markers, proteomics, and micro RNA are not currently applicable for routine work in IVF Labs.
  • 47. Conclusions 10 - The future is for genetic testing. aneuploidy screening + single gene defect + mt DNA content at the same time. (69-72% implantation rates)
  • 48. Conclusions 11 -1n poor prognosis patients we have to give every single embryo a chance. 12- Combining morphological evaluation, cytogenetical analysis, and embryo metabolism will increase the ability to select the most viable embryo out of a pool.
  • 49. Everyone is a miracle in miniature with a personal history of men and women who lived, loved, and gave birth to others ever since the creation of mankind. Harvey Graham 1950 No body is genetically perfect